These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 27496656)
1. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia. Bulka CM; Terekhov MA; Martin BJ; Dmochowski RR; Hayes RM; Ehrenfeld JM Anesthesiology; 2016 Oct; 125(4):647-55. PubMed ID: 27496656 [TBL] [Abstract][Full Text] [Related]
2. Intermediate-Acting Nondepolarizing Neuromuscular Blocking Agents and Risk of Postoperative 30-Day Morbidity and Mortality, and Long-term Survival. Bronsert MR; Henderson WG; Monk TG; Richman JS; Nguyen JD; Sum-Ping JT; Mangione MP; Higley B; Hammermeister KE Anesth Analg; 2017 May; 124(5):1476-1483. PubMed ID: 28244947 [TBL] [Abstract][Full Text] [Related]
3. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: A single center study. Belcher AW; Leung S; Cohen B; Yang D; Mascha EJ; Turan A; Saager L; Ruetzler K J Clin Anesth; 2017 Dec; 43():33-38. PubMed ID: 28972924 [TBL] [Abstract][Full Text] [Related]
4. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial. Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520 [TBL] [Abstract][Full Text] [Related]
5. Association between reversal agents (sugammadex vs. neostigmine) for neuromuscular block and postoperative pulmonary complications: A retrospective analysis. Ren A; Fan M; Gu Z; Liang X; Xu L; Liu C; Wang D; Chang H; Zhu M Br J Clin Pharmacol; 2024 Jul; 90(7):1667-1676. PubMed ID: 38583490 [TBL] [Abstract][Full Text] [Related]
6. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study. Saager L; Maiese EM; Bash LD; Meyer TA; Minkowitz H; Groudine S; Philip BK; Tanaka P; Gan TJ; Rodriguez-Blanco Y; Soto R; Heisel O J Clin Anesth; 2019 Aug; 55():33-41. PubMed ID: 30594097 [TBL] [Abstract][Full Text] [Related]
8. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472 [TBL] [Abstract][Full Text] [Related]
9. Effects of calcium chloride coadministered with neostigmine on neuromuscular blockade recovery: A double-blind randomised study. Ju JW; Kim HC; Yoon S; Hong DM; Park HP Eur J Anaesthesiol; 2017 Sep; 34(9):617-622. PubMed ID: 28763316 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. Carron M; Zarantonello F; Tellaroli P; Ori C J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504 [TBL] [Abstract][Full Text] [Related]
12. Observational study on patterns of neuromuscular blockade reversal. Dubovoy T; Housey M; Devine S; Kheterpal S BMC Anesthesiol; 2016 Oct; 16(1):103. PubMed ID: 27770778 [TBL] [Abstract][Full Text] [Related]
13. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Sacan O; White PF; Tufanogullari B; Klein K Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210 [TBL] [Abstract][Full Text] [Related]
14. Intraoperative Use of Nondepolarizing Neuromuscular Blocking Agents During Cardiac Surgery and Postoperative Pulmonary Complications: A Prospective Randomized Trial. Gerlach RM; Shahul S; Wroblewski KE; Cotter EKH; Perkins BW; Harrison JH; Ota T; Jeevanandam V; Chaney MA J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1673-1681. PubMed ID: 30655198 [TBL] [Abstract][Full Text] [Related]
15. Postoperative Pulmonary Complications' Association with Sugammadex versus Neostigmine: A Retrospective Registry Analysis. Li G; Freundlich RE; Gupta RK; Hayhurst CJ; Le CH; Martin BJ; Shotwell MS; Wanderer JP Anesthesiology; 2021 Jun; 134(6):862-873. PubMed ID: 33730169 [TBL] [Abstract][Full Text] [Related]
16. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal. Ledowski T; Falke L; Johnston F; Gillies E; Greenaway M; De Mel A; Tiong WS; Phillips M Eur J Anaesthesiol; 2014 Aug; 31(8):423-9. PubMed ID: 24296853 [TBL] [Abstract][Full Text] [Related]
17. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children. Ammar AS; Mahmoud KM; Kasemy ZA Acta Anaesthesiol Scand; 2017 Apr; 61(4):374-380. PubMed ID: 28185260 [TBL] [Abstract][Full Text] [Related]
18. Neostigmine product for NMBA reversal approved by FDA. Thompson CA Am J Health Syst Pharm; 2013 Jul; 70(14):1184. PubMed ID: 23820450 [No Abstract] [Full Text] [Related]
19. Implementation of a new strategy to improve the peri-operative management of neuromuscular blockade and its effects on postoperative pulmonary complications. Rudolph MI; Chitilian HV; Ng PY; Timm FP; Agarwala AV; Doney AB; Ramachandran SK; Houle TT; Eikermann M Anaesthesia; 2018 Sep; 73(9):1067-1078. PubMed ID: 29974459 [TBL] [Abstract][Full Text] [Related]
20. Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications. McLean DJ; Diaz-Gil D; Farhan HN; Ladha KS; Kurth T; Eikermann M Anesthesiology; 2015 Jun; 122(6):1201-13. PubMed ID: 25919486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]